BLACKLINE INC (BL)

US09239B1098 - Common Stock

62.48  -0.95 (-1.5%)

Fundamental Rating

6

Overall BL gets a fundamental rating of 6 out of 10. We evaluated BL against 280 industry peers in the Software industry. BL has an average financial health and profitability rating. BL is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, BL could be worth investigating further for growth investing!.



6

1. Profitability

1.1 Basic Checks

In the past year BL was profitable.
In the past year BL had a positive cash flow from operations.
In the past 5 years BL reported 4 times negative net income.
In the past 5 years BL always reported a positive cash flow from operatings.

1.2 Ratios

BL has a Return On Assets of 7.48%. This is amongst the best in the industry. BL outperforms 81.72% of its industry peers.
With an excellent Return On Equity value of 34.47%, BL belongs to the best of the industry, outperforming 92.47% of the companies in the same industry.
The Return On Invested Capital of BL (1.68%) is better than 66.67% of its industry peers.
Industry RankSector Rank
ROA 7.48%
ROE 34.47%
ROIC 1.68%
ROA(3y)-1.78%
ROA(5y)-2.55%
ROE(3y)-13.82%
ROE(5y)-12.15%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BL's Profit Margin of 19.83% is amongst the best of the industry. BL outperforms 87.10% of its industry peers.
With a decent Operating Margin value of 4.38%, BL is doing good in the industry, outperforming 69.89% of the companies in the same industry.
BL has a better Gross Margin (75.27%) than 67.74% of its industry peers.
BL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.38%
PM (TTM) 19.83%
GM 75.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.24%
GM growth 5Y-0.66%

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BL is destroying value.
Compared to 1 year ago, BL has more shares outstanding
Compared to 5 years ago, BL has more shares outstanding
Compared to 1 year ago, BL has an improved debt to assets ratio.

2.2 Solvency

BL has an Altman-Z score of 2.58. This is not the best score and indicates that BL is in the grey zone with still only limited risk for bankruptcy at the moment.
BL's Altman-Z score of 2.58 is in line compared to the rest of the industry. BL outperforms 48.03% of its industry peers.
BL has a debt to FCF ratio of 5.48. This is a neutral value as BL would need 5.48 years to pay back of all of its debts.
BL has a Debt to FCF ratio (5.48) which is in line with its industry peers.
BL has a Debt/Equity ratio of 2.42. This is a high value indicating a heavy dependency on external financing.
BL has a worse Debt to Equity ratio (2.42) than 84.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.42
Debt/FCF 5.48
Altman-Z 2.58
ROIC/WACC0.16
WACC10.34%

2.3 Liquidity

A Current Ratio of 2.69 indicates that BL has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.69, BL is in the better half of the industry, outperforming 72.76% of the companies in the same industry.
A Quick Ratio of 2.69 indicates that BL has no problem at all paying its short term obligations.
BL's Quick ratio of 2.69 is fine compared to the rest of the industry. BL outperforms 73.12% of its industry peers.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 2.69

8

3. Growth

3.1 Past

BL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.69%, which is quite impressive.
Measured over the past years, BL shows a very strong growth in Earnings Per Share. The EPS has been growing by 74.65% on average per year.
Looking at the last year, BL shows a quite strong growth in Revenue. The Revenue has grown by 11.37% in the last year.
BL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.96% yearly.
EPS 1Y (TTM)49.69%
EPS 3Y36.9%
EPS 5Y74.65%
EPS Q2Q%17.65%
Revenue 1Y (TTM)11.37%
Revenue growth 3Y18.82%
Revenue growth 5Y20.96%
Sales Q2Q%10.09%

3.2 Future

Based on estimates for the next years, BL will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.60% on average per year.
BL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.95% yearly.
EPS Next Y15.34%
EPS Next 2Y9.48%
EPS Next 3Y10.6%
EPS Next 5YN/A
Revenue Next Year10.76%
Revenue Next 2Y9.89%
Revenue Next 3Y10.04%
Revenue Next 5Y8.95%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 25.93 indicates a quite expensive valuation of BL.
Based on the Price/Earnings ratio, BL is valued a bit cheaper than 75.63% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.20, BL is valued at the same level.
With a Price/Forward Earnings ratio of 26.73, BL can be considered very expensive at the moment.
72.04% of the companies in the same industry are more expensive than BL, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of BL to the average of the S&P500 Index (23.73), we can say BL is valued inline with the index average.
Industry RankSector Rank
PE 25.93
Fwd PE 26.73

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BL indicates a somewhat cheap valuation: BL is cheaper than 68.46% of the companies listed in the same industry.
81.72% of the companies in the same industry are more expensive than BL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 23.98
EV/EBITDA 49.18

4.3 Compensation for Growth

BL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.69
PEG (5Y)0.35
EPS Next 2Y9.48%
EPS Next 3Y10.6%

0

5. Dividend

5.1 Amount

No dividends for BL!.
Industry RankSector Rank
Dividend Yield N/A

BLACKLINE INC

NASDAQ:BL (12/23/2024, 12:38:37 PM)

62.48

-0.95 (-1.5%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-11 2025-02-11/amc
Inst Owners92.76%
Inst Owner Change-2.45%
Ins Owners8.16%
Ins Owner Change-5.01%
Market Cap3.90B
Analysts52.38
Price Target64.97 (3.99%)
Short Float %9.04%
Short Ratio7.5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.38%
Min EPS beat(2)11.9%
Max EPS beat(2)12.86%
EPS beat(4)4
Avg EPS beat(4)14.57%
Min EPS beat(4)11.6%
Max EPS beat(4)21.9%
EPS beat(8)8
Avg EPS beat(8)42.69%
EPS beat(12)11
Avg EPS beat(12)119.11%
EPS beat(16)15
Avg EPS beat(16)118.39%
Revenue beat(2)0
Avg Revenue beat(2)-1.37%
Min Revenue beat(2)-1.5%
Max Revenue beat(2)-1.24%
Revenue beat(4)0
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-2%
Max Revenue beat(4)-1.24%
Revenue beat(8)0
Avg Revenue beat(8)-1.98%
Revenue beat(12)0
Avg Revenue beat(12)-2%
Revenue beat(16)1
Avg Revenue beat(16)-1.58%
PT rev (1m)10.21%
PT rev (3m)12.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.16%
EPS NY rev (1m)1.99%
EPS NY rev (3m)2.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.05%
Revenue NY rev (1m)0.39%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE 25.93
Fwd PE 26.73
P/S 6.1
P/FCF 23.98
P/OCF 20.63
P/B 10.61
P/tB N/A
EV/EBITDA 49.18
EPS(TTM)2.41
EY3.86%
EPS(NY)2.34
Fwd EY3.74%
FCF(TTM)2.61
FCFY4.17%
OCF(TTM)3.03
OCFY4.85%
SpS10.24
BVpS5.89
TBVpS-3.01
PEG (NY)1.69
PEG (5Y)0.35
Profitability
Industry RankSector Rank
ROA 7.48%
ROE 34.47%
ROCE 2.13%
ROIC 1.68%
ROICexc 4.69%
ROICexgc N/A
OM 4.38%
PM (TTM) 19.83%
GM 75.27%
FCFM 25.45%
ROA(3y)-1.78%
ROA(5y)-2.55%
ROE(3y)-13.82%
ROE(5y)-12.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.24%
GM growth 5Y-0.66%
F-Score9
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 2.42
Debt/FCF 5.48
Debt/EBITDA 11.28
Cap/Depr 51.73%
Cap/Sales 4.13%
Interest Coverage 250
Cash Conversion 239.31%
Profit Quality 128.37%
Current Ratio 2.69
Quick Ratio 2.69
Altman-Z 2.58
F-Score9
WACC10.34%
ROIC/WACC0.16
Cap/Depr(3y)70.45%
Cap/Depr(5y)69.97%
Cap/Sales(3y)5.31%
Cap/Sales(5y)4.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.69%
EPS 3Y36.9%
EPS 5Y74.65%
EPS Q2Q%17.65%
EPS Next Y15.34%
EPS Next 2Y9.48%
EPS Next 3Y10.6%
EPS Next 5YN/A
Revenue 1Y (TTM)11.37%
Revenue growth 3Y18.82%
Revenue growth 5Y20.96%
Sales Q2Q%10.09%
Revenue Next Year10.76%
Revenue Next 2Y9.89%
Revenue Next 3Y10.04%
Revenue Next 5Y8.95%
EBIT growth 1Y52.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year84.46%
EBIT Next 3Y35.5%
EBIT Next 5YN/A
FCF growth 1Y680.48%
FCF growth 3Y41%
FCF growth 5Y88.32%
OCF growth 1Y261.24%
OCF growth 3Y32.25%
OCF growth 5Y50.98%